Suggestions
Renu Bhatia
Chairman at Opharmic Technology
Renu Bhatia is a prominent figure in Hong Kong's financial and healthcare sectors, currently serving as the Chairman of the Listing Committee of the Hong Kong Stock Exchange (HKEX). Here's a comprehensive overview of her background and achievements:
Professional Background
HKEX Listing Committee: Renu Bhatia has been a member of the HKEX Listing Committee since 2019 and was appointed as its Chairman in 2023.12 She has been re-appointed to this position in 2024, highlighting her continued leadership in this crucial role.2
Healthcare and Technology: Dr. Bhatia is the Chairman and co-founder of Opharmic Technology (HK) Ltd, a company developing ultrasound technology for non-invasive drug delivery to the eyes.34 This role showcases her expertise in healthcare innovation and entrepreneurship.
Financial Sector: With over 25 years of experience, Dr. Bhatia has a diverse background spanning healthcare, finance, fintech, and regulatory sectors.4 She co-founded Asia Fintech Angels, which invests in early-stage fintech companies.4
Education and Qualifications
- Doctor of Medicine (MBBS) from the University of London
- Master of Business Administration from Yale University
- Postgraduate Diploma in Therapeutics and Medicine from The University of Hong Kong4
Board Positions and Public Service
- Independent Non-executive Director of Overstone Associates Limited
- Member of the Business Professional Federation Healthcare Committee
- Member of the Cyberport Entrepreneurship Centre Advisory Group
- Assessor for the Hong Kong Enterprise Support Scheme Assessment Panel of the Innovation and Technology Fund4
Career Journey
Dr. Bhatia's career path is unique and multifaceted:
- Started as a medical doctor
- Transitioned to finance, working at Goldman Sachs and HSBC Asset Management
- Developed interests in healthcare economics and technology innovation
- Co-founded Opharmic Technology, combining her medical and business expertise
- Actively involved in fintech and regulatory roles, including her position at HKEX3
Expertise and Contributions
Dr. Bhatia brings a wealth of experience to her roles, particularly in:
- Healthcare innovation and technology
- Financial markets and regulations
- Corporate governance
- Board diversity and inclusion
Her diverse background allows her to offer unique perspectives in board discussions and contribute to the development of Hong Kong's financial markets.3
Dr. Bhatia is known for her proactive approach to seeking opportunities and her advocacy for board diversity. She emphasizes the importance of having diverse viewpoints and skills on boards to navigate complex business environments and improve corporate governance.3